Natrelle® Partners with Vizient to Enhance Client Access to Premium Breast Implants

In a significant move for healthcare providers, Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has recently announced that its iconic Natrelle® breast implant line has been selected as a supplier for Vizient, Inc. This partnership marks a pivotal milestone as it connects Natrelle® with the nation's largest provider-driven healthcare performance improvement organization, allowing clients enhanced access to a vast array of breast implant options.

Strengthening Healthcare Solutions

The agreement is particularly beneficial for Vizient's extensive network, which comprises a multitude of academic medical centers, community hospitals, integrated delivery networks, and non-acute care providers. This network represents more than half of the healthcare organizations in the United States, highlighting the reach and impact of this collaboration. With this agreement, Vizient clients will benefit from improved access to Natrelle®’s extensive offerings, including over 300 different breast implant options within the most comprehensive range available in the market today.

Glen Curran, Senior Vice President of U.S. Allergan Aesthetics, expressed excitement about the partnership, stating, "This agreement with Vizient underscores our commitment to supporting women through their breast reconstruction journeys while equipping providers with the tools they need to deliver exceptional care." The implementation of this agreement aims not only to provide healthcare professionals with competitive pricing and a more streamlined procurement process but also to enhance operational efficiency and provide robust support from experienced sales and technical teams.

The Commitment to Personalized Care

The Natrelle® line is built upon a 50-year legacy of excellence in aesthetic science and innovation. It has established itself as the leading choice among plastic surgeons for breast implants, emphasizing Allergan's dedication to delivering high-quality and personalized patient care. The wide range of implant choices allows for tailored outcomes that can meet the unique needs of each individual, further ensuring that healthcare providers can offer optimal solutions to their patients.

As part of this agreement, Natrelle® will also provide necessary tools and training resources for Vizient's providers, thereby fostering an environment of ongoing education and support. By equipping healthcare professionals with the knowledge and skills to utilize these advanced products effectively, Allergan Aesthetics aims to empower them in delivering top-tier patient experiences.

A Legacy of Safety and Innovation

Allergan has consistently pushed the boundaries of aesthetic procedures while maintaining a firm commitment to patient safety. However, the company also stresses the importance of being informed about breast implant risks. Patients considering Natrelle® Breast Implants should be aware that these devices are not designed to be lifelong implants. With prolonged use, the chances of developing certain complications increase, making it crucial for patients and providers alike to stay educated about the associated risks of breast augmentation and reconstruction surgeries.

Importantly, Natrelle® surfaces have been linked to various health considerations, including complications such as reoperation and rare conditions like breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The company underscores the importance of discussing these potential risks with healthcare providers prior to undergoing any procedures.

Future Outlook

The partnership between Natrelle® and Vizient marks an optimistic step forward for healthcare providers, ensuring that more patients can access leading implant technologies while enhancing overall operational effectiveness in medical settings. As both organizations move forward, they continue to prioritize the well-being and safety of patients undergoing breast augmentation and reconstruction.

For anyone looking to explore their options further, more information can be found at Natrelle.com.

With a legacy rooted in innovation and a commitment to patient-centric outcomes, the collaboration between Natrelle® and Vizient paints a promising picture for the future of aesthetic surgery and patient care.